Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

596
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
596
Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

72
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
72
Time Course of Drug Effect01:14

Time Course of Drug Effect

2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
Steady State Concentration01:05

Steady State Concentration

4.3K
A steady state refers to the level of a drug in the body once it has reached an equilibrium between administration and elimination. It represents the point at which the drug administration rate equals the drug elimination rate, resulting in a relatively constant concentration in the body over time. The dynamic equilibrium is crucial to ensure the drug's effectiveness with minimal risk of toxicity.
Most drugs are administered in repeated doses at fixed intervals or through continuous...
4.3K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

104
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
104
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

347
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
347

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Impact of Frontline Systemic Treatment Choice on Clinical Outcome in Advanced Leiomyosarcoma: A CanSaRCC Study.

Cancer medicine·2026
Same author

Improving Generalizability in Whole-Cell Antibiotic Discovery Through Active Learning.

bioRxiv : the preprint server for biology·2026
Same author

Long-Term Outcomes of Sacral Neuromodulation Explantation: A 12-Year Experience at a High-Volume Tertiary Center.

Neurourology and urodynamics·2026
Same author

Real-World Long-Term Outcomes of Rezūm Therapy for Large-Volume Benign Prostatic Hyperplasia: A Multicenter Cohort Study.

Lower urinary tract symptoms·2026
Same author

Association of Cumulative Proton Pump Inhibitor Use with Prostate Cancer Risk and Outcomes: A Population-Based Cohort Study.

Cancer research communications·2026
Same author

Predictors of surgical retreatment following Rezūm water vapor therapy: a multi-center real-world cohort study.

World journal of urology·2026

相关实验视频

Updated: Jun 14, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K

前列腺组织中的他酸度依赖亚型和剂量.

Julian Chavarriaga1, Linda Z Penn2, Najia Khurram3

  • 1Division of Urology, Department of Surgical Oncology, University Health Network & University of Toronto, Toronto, ON, Canada; Cancer Treatment and Research Centre (CTIC) Luis Carlos Sarmiento Angulo Foundation, Bogota, Colombia.

Urology
|September 2, 2024
PubMed
概括

像罗斯瓦斯塔丁这样的水友性他类药物比阿托瓦斯塔丁这样的脂友性他类药物达到更高的前列腺组织度. 前列腺组织中的他类药物水平是剂量依赖的,前列腺癌患者中发现了可测量的量量.

更多相关视频

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
07:12

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells

Published on: September 9, 2021

3.5K
Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
08:40

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging

Published on: April 8, 2016

12.8K

相关实验视频

Last Updated: Jun 14, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K
Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
07:12

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells

Published on: September 9, 2021

3.5K
Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
08:40

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging

Published on: April 8, 2016

12.8K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 在瘤学瘤学.
  • 药用化学 医学化学

背景情况:

  • 类药物被广泛用于胆固醇管理.
  • 了解组织特异性他类药物分布对于治疗优化至关重要.
  • 脂友性和水友性他类药物表现出不同的药理动力学特性.

研究的目的:

  • 为了比较血清和前列腺组织度的脂友和友的他类药物.
  • 为了研究前列腺组织中他类药物度的剂量依赖性.
  • 为提供前列腺组织中他类药物度的第一次比较分析.

主要方法:

  • 对80名接受激进前列腺切除术的患者进行了回顾性分析.
  • 选择治疗阿托瓦斯塔丁 (脂性) 或罗斯瓦斯塔丁 (水性) 的患者.
  • 使用HPLC质谱测量量血清和前列腺组织中他类度的量化.

主要成果:

  • 与阿托瓦斯塔丁 (脂性) (0.96 ng/g) 相比,罗斯瓦斯塔丁 (性) 的中位前列腺组织度显著更高 (3.98 ng/g).
  • 可测量的他类药物度在服用罗斯瓦斯他的患者中被发现为53.6%,而服用阿托瓦斯他的患者为38.4%.
  • 对于罗斯瓦斯塔丁,观察到明显的剂量依赖性,高剂量 (5.21 ng/g) 与低剂量 (1.99 ng/g) 的度更高.

结论:

  • 脂友性和水友性他可以在前列腺癌组织中测量.
  • 前列腺组织中的他类药物度取决于药物的脂性和剂量.
  • 水友性他类药物,特别是罗斯瓦斯塔丁,在前列腺组织中达到明显更高的度.